Odor identification and decline in different cognitive domains in old age

Neuroepidemiology

Volumn 26, Issue 2, 2006, Pages 61-67

  Wilson, Robert S ^a,c   Arnold, Steven E ^d   Tang, Yuxiao ^b,c   Bennett, David A ^a,c  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cognitive function; Episodic memory; Longitudinal studies; Olfactory identification; Perceptual speed

Indexed keywords

AGE; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CIGARETTE SMOKING; COGNITION; COGNITIVE DEFECT; DEMOGRAPHY; EDUCATION; HUMAN; MAJOR CLINICAL STUDY; OLFACTORY DISCRIMINATION; PERCEPTIVE DISCRIMINATION; RISK FACTOR; SCORING SYSTEM; SEX DIFFERENCE; STROKE; WORKING MEMORY;

AGED; AGED, 80 AND OVER; AGING; COGNITION DISORDERS; FEMALE; HUMANS; MALE; OLFACTION DISORDERS;

EID: 32044434645     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090250     Document Type: Article

References (55)

1. Lehrner JP, Gluck J, Laska M: Odor identification, consistency of label use, olfactory threshold and their relationship to odor memory over the human lifespan. Chem Senses 1999;24:337-346.
2. Murphy C, Schubert CR, Cruisckshanks KJ, Klein BEK, Klein R, Nondahl DM: Prevalence of olfactory impairment in older adults. JAMA 2002;288:2307-2312.
3. Russell MJ, Cummings BF, Profitt BF, Wysocki CJ, Gilbert AN, Cotman CW: Life span changes in the verbal categorization of odors. J Gerontol Psychol Sci 1993;48:P49-P53.
4. Ship JA, Pearson JD, Cruise LJ, Brant LJ, Metter EJ: Longitudinal changes in smell identification. J Gerontol Med Sci 1996;51:M86-M91.
5. Devanand DP, Michaels-Marston KS, Liu X, et al: Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. Am J Psychiatry 2000;157:1399-1405.
6. Larsson M, Nilsson LG, Olofsson JK, Nordin S: Demographic and cognitive predictors of cued odor identification: evidence from a population-based study. Chem Senses 2004;29:547-554.
7. Finkel D, Pedersen NL, Larsson M: Olfactory functioning and cognitive abilities: a twin study. J Gerontol Psychol Sci 2001;56B:P226-P233.
8. Nordin S, Murphy C: Impaired sensory and cognitive olfactory function in questionable Alzheimer's disease. Neuropsychology 1996;10:113-119.
9. Peters JM, Hummell T, Kratzsch T, Lostsch J, Skarke C, Frolich L: Olfactory function in mild cognitive impairment and Alzheimer's disease: an investigation using psychophysical and electrophysiological techniques. Am J Psychiatry 2003;160:1995-2002.
10. Wang Q-S, Tian L, Huang Y-L, Qin S, He L-Q, Zhou J-N: Olfactory identification and apolipoprotein E ε4 in mild cognitive impairment. Brain Res 2002;951:77-81.
11. Royet JP, Croisile JB, Williamson-Vasta R, Hibert O, Serclerat D, Guerin J: Rating of different olfactory judgments in Alzheimer's disease. Chem Senses 2001;26:409-417.
12. Serby M, Larson P, Kalkstein D: The nature and course of olfactory deficits in Alzheimer's disease. Am J Psychiatry 1991;418:357-360.
13. Mesholam RI, Moberg PJ, Mahr RN, Doty RL: Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. Arch Neurol 1998;55:84-90.
14. Double KL, Rowe DB, Hayes M, et al: Identifying the pattern of olfactory deficits in Parkinson's disease using the Brief Smell Identification Test. Arch Neurol 2003;60:545-549.
15. Hudry J, Thobois S, Broussolle E, Adeleine P, Royet JP: Evidence for deficiencies in perceptual and semantic olfactory processes in Parkinson's disease. Chem Senses 2003;28:537-543.
16. Nordin S, Paulsen JS, Murphy C: Sensory-and memory-mediated olfactory dysfunction in Huntington's disease. J Int Neuropsychol Soc 1995;1:281-290.
17. Graves AB, Bowen JD, Rajaram L, et al: Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E ε4 status. Neurology 1999;53:1480-1487.
18. Royall DR, Chiodo LK, Polk MJ, Jaramillo CJ: Severe dysosmia is specifically associated with Alzheimer-like memory deficits in nondemented elderly retirees. Neuroepidemiology 2002;21:68-73.
19. Swan GE, Carmelli D: Impaired olfaction predicts cognitive decline in nondemented older adults. Neuroepidemiology 2002;21:58-67.
20. Rogosa D, Brandt D, Zimowski M: A growth curve approach to the measurement of change. Psychol Bull 1982;92:726-748.
21. Bennett DA, Schneider JA, Buchman AS, Mendes de Leon CF, Bienias JL, Wilson RS: The Rush Memory and Aging Project: study design and baseline characteristics of the study cohort. Neuroepidemiology 2005;25:163-175.
22. Wilson RS, Barnes LL, Bennett DA: Assessment of lifetime participation in cognitively stimulating activities. J Clin Exp Neuropsychol 2003;25:634-642.
23. Wilson RS, Barnes LL, Krueger KR, Hoganson G, Bienias JL, Bennett DA: Early and late life cognitive activity and cognitive systems in old age. J Int Neuropsychol Soc 2005;11:400-407.
24. McKhann G, Drachman D, Holstein M, Katzman R, Price D, Stadlan E: Clinical diagnosis of Alzheimer's disease: report of the NINCDS/ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
25. Doty RL, Marcus A, Lee WW: Development of the 12-item Cross-Cultural Smell Identification Test (CC-SIT). Laryngoscope 1996;106:353-356.
26. Doty RL, Frye RE, Agrawal U: Internal consistency reliability of the fractionated and whole University of Pennsylvania Smell Identification Test. Percept Psychophys 1989;45:381-384.
27. Smith A: Symbol Digit Modalities Test manual-revised. Los Angeles, Western Psychological Services, 1982.
28. Ekstrom RB, French JW, Harman HH, Kermen D: Manual for kit of factor-referenced cognitive tests. Princeton, Educational Testing Service, 1976.
29. Trenerry MR, Crosson B, DeBoe J, Leber WR: The Stroop Neuropsychological Screening Test. Odessa, Psychological Assessment Resources, 1989.
30. Morris J, Heyman A, Mohs R, et al: The consortium to establish a registry for Alzheimer's disease (CERAD). I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159-1165.
31. Albert M, Smith L, Scherr P, Taylor J, Evans D, Funkenstein H: Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease. Int J Neurosci 1991;57:167-178.
32. Wilson RS, Beckett LA, Barnes LL, et al: Individual differences in rates of change in cognitive abilities of older persons. Psychol Aging 2002;17:179-193.
33. Wechsler D: Wechsler Memory Scale-Revised manual. San Antonio, Psychological Corporation, 1987.
34. Kaplan EF, Goodglass H, Weintraub S: The Boston Naming Test. Philadelphia, Lea & Febiger, 1983.
35. Nelson HE: National Adult Reading Test (NART): test manual. Windsor, NFER Nelson, 1982.
36. Cooper JA, Sager HJ: Incidental and intentional recall in Parkinson's disease: an account based on diminished attentional resources. J Clin Exp Neuropsychol 1993;15:713-731.
37. Benton AL, Sivan AB, Hamsher K, Varney NR, Spreen O: Contributions to Neuropsychologial Assessment, ed 2. New York, Oxford University Press, 1994.
38. Raven JC, Court JH, Raven T: Manual for Raven's Progressive Matrices and Vocabulary: Standard Progressive Matrices. Oxford, Oxford Psychologists Press, 1992.
39. Laird N, Ware J: Random-effects models for longitudinal data. Biometrics 1982;38:963-974.
40. Wilson RS, Gilley DW, Bennett DA, Beckett LA, Evans DA: Person-specific paths of cognitive decline in Alzheimer's disease and their relation to age. Psychol Aging 2000;15:18-28.
41. SAS Institute Inc. SAS/STAT® User's Guide, Version 8. Cary, SAS Institute, 2000.
42. Ohm TG, Braak H: Olfactory bulb changes in Alzheimer's disease. Acta Neuropathol 1987;73:365-369.
43. Tsuboi Y, Wszolek ZK, Graff-Radford NR, Cookson N, Dickson DW: Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon 4. Neuropathol Appl Neurobiol 2003;29:503-510.
44. Arnold SE, Hyman BT, Flory T, Damasio AR, van Hoesen GW: The topographical and neuroanaotomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex 1991;1:103-116.
45. Braak H, Break E: The human entorphinal cortex: normal morphology and lamina-specific pathology in various diseases. Neurosci Res 1992;15:6-31.
46. van Hoesen GW, Parvizi J, Chu CC: Orbitofrontal cortex pathology in Alzheimer's disease. Cereb Cortex 2000;10:243-251.
47. Chu CC, Tranel D, Damasio AR, van Hoesen GW: The autonomic-related cortex: pathology in Alzheimer's disease. Cereb Cortex 1997;6:530-539.
48. Alvarez P, Squire LR: Memory consolidation and the medial temporal lobe: a simple network model. Proc Natl Acad Sci USA 1994;91:7041-7045.
49. Stuss DT, Alexander MP, Shallice T, Picton TW, Binns MA, Macdonald R, Borowiec A, Katz DI: Multiple frontal systems controlling response speed. Neuropsychologia 2005;43:396-417.
50. Stuss DT, Floden D, Alexander MP, Levine B, Katz D: Stroop performance ill focal lesion patients: dissociation of processes and frontal lobe lesion location. Neuropsychologia 2001;39:771-786.
51. Kerns JG, Cohen JD, MacDonald AW, Cho RY, Stenger VA, Carter CS: Anterior cingulate conflict monitoring and adjustments in control. Science 2004;303:1023-1026.
52. Langenecker SA, Nelson KA, Rao SM: fMRI of healthy older adults during Stroop interference. Neuroimage 2004;21:192-200.
53. MacDonald AW, Cohen JD, Stenger VA, Carter CS: Dissociating the role of the dorsolateral prefrontal and anterior cingulate cortex in cognitive control. Science 2000;288:1835-1838.
54. Dulay MF, Murphy C: Olfactory activity and cognitive function converge in older adulthood: support for the common cause hypothesis. Psychol Aging 2002;17:392-404.
55. Wilson DA, Stevenson RJ: The fundamental role of memory in olfactory perception. Trends Neurosci 2003;26:243-247.